A rise in CD20+ B-cells in the tumor border region is associated with a positive prognosis and is connected to a smaller size of tumor, a lack of vascular invasion, and an increase in CD8+ T lymphocyte concentration, particularly in HBV-associated HCC [141]. This evidence concerns the gene CD8A and hepatocellular carcinoma.